{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T16:07:32Z","timestamp":1794586052250,"version":"4.9.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T00:00:00Z","timestamp":1628812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T00:00:00Z","timestamp":1628812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["1K08HL141635-01A1"],"award-info":[{"award-number":["1K08HL141635-01A1"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["K12HD072245"],"award-info":[{"award-number":["K12HD072245"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1038\/s41434-021-00283-5","type":"journal-article","created":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T01:02:35Z","timestamp":1628816555000},"page":"1-12","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Thrombopoietin-based CAR-T cells demonstrate in vitro and in vivo cytotoxicity to MPL positive acute myelogenous leukemia and hematopoietic stem cells"],"prefix":"10.1038","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7914-4610","authenticated-orcid":false,"given":"Jaquelyn T.","family":"Zoine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyu","family":"Prince","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie Y.","family":"Story","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3025-7977","authenticated-orcid":false,"given":"Gianna M.","family":"Branella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison M.","family":"Lytle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Fedanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan S.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C.","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher B.","family":"Doering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Trent","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8007-9932","authenticated-orcid":false,"given":"Shanmuganathan","family":"Chandrakasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,13]]},"reference":[{"key":"283_CR1","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1158\/2159-8290.CD-12-0548","volume":"3","author":"M Sadelain","year":"2013","unstructured":"Sadelain M, Brentjens R, Rivi\u00e8re I. The basic principles of chimeric antigen receptor design. Cancer Discov. 2013;3:388\u201398.","journal-title":"Cancer Discov"},{"key":"283_CR2","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/0076-6879(91)03005-2","volume":"203","author":"JS Huston MM-H","year":"1991","unstructured":"Huston MM-H JS, Tai MS, McCartney J, Warren F, Haber E, Oppermann. H. Protein engineering of single-chain Fv analogs and fusion proteins. Methods Enzymol. 1991;203:46\u201352.","journal-title":"Methods Enzymol"},{"key":"283_CR3","doi-asserted-by":"publisher","first-page":"177ra38","DOI":"10.1126\/scitranslmed.3005930","volume":"5","author":"RJ Brentjens","year":"2013","unstructured":"Brentjens RJ, Davila ML, Riviere I, Park J, Wang X, Cowell LG, et al. CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia. Sci Transl Med. 2013;5:177ra38.","journal-title":"Sci Transl Med"},{"key":"283_CR4","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.molmed.2017.03.002","volume":"23","author":"ZL Chang","year":"2017","unstructured":"Chang ZL, Chen YY. CARs: synthetic immunoreceptors for cancer therapy and beyond. Trends Mol Med. 2017;23:430\u201350.","journal-title":"Trends Mol Med"},{"key":"283_CR5","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1056\/NEJMoa1215134","volume":"368","author":"SA Grupp","year":"2013","unstructured":"Grupp SA, Kalos M, Barrett D, Aplenc R, Porter DL, Rheingold SR, et al. Chimeric antigen receptor-modified T cells for acute lymphoid leukemia. N Engl J Med. 2013;368:1509\u201318.","journal-title":"N Engl J Med"},{"key":"283_CR6","doi-asserted-by":"publisher","first-page":"4129","DOI":"10.1182\/blood-2013-08-519413","volume":"122","author":"JN Kochenderfer","year":"2013","unstructured":"Kochenderfer JN, Dudley ME, Carpenter RO, Kassim SH, Rose JJ, Telford WG, et al. Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation. Blood. 2013;122:4129\u201339.","journal-title":"Blood"},{"key":"283_CR7","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1517\/14712598.2015.1046430","volume":"15","author":"M Chmielewski","year":"2015","unstructured":"Chmielewski M, Abken H. TRUCKs: the fourth generation of CARs. Expert Opin Biol Ther. 2015;15:1145\u201354.","journal-title":"Expert Opin Biol Ther"},{"key":"283_CR8","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s13046-018-0817-0","volume":"37","author":"MH Townsend","year":"2018","unstructured":"Townsend MH, Shrestha G, Robison RA, O\u2019Neill KL. The expansion of targetable biomarkers for CAR T cell therapy. J Exp Clin Cancer Res. 2018;37:163.","journal-title":"J Exp Clin Cancer Res"},{"key":"283_CR9","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.beha.2018.03.003","volume":"31","author":"JM Murad","year":"2018","unstructured":"Murad JM, Graber DJ, Sentman CL. Advances in the use of natural receptor- or ligand-based chimeric antigen receptors (CARs) in haematologic malignancies. Best Pract Res Clin Haematol. 2018;31:176\u201383.","journal-title":"Best Pract Res Clin Haematol"},{"key":"283_CR10","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/369565a0","volume":"369","author":"S Lok","year":"1994","unstructured":"Lok S, Kaushansky K, Holly RD, Kuijper JL, Lofton-Day CE, Oort PJ, et al. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature. 1994;369:565\u20138.","journal-title":"Nature"},{"key":"283_CR11","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1172\/JCI0215430","volume":"110","author":"N Fox","year":"2002","unstructured":"Fox N, Priestley G, Papayannopoulou T, Kaushansky K. Thrombopoietin expands hematopoietic stem cells after transplantation. J Clin Investig. 2002;110:389\u201394.","journal-title":"J Clin Investig"},{"key":"283_CR12","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/369568a0","volume":"369","author":"K Kaushansky","year":"1994","unstructured":"Kaushansky K, Lok S, Holly RD, Broudy VC, Lin N, Bailey MC, et al. Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature. 1994;369:568\u201371.","journal-title":"Nature"},{"key":"283_CR13","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.stem.2007.10.020","volume":"1","author":"H Yoshihara","year":"2007","unstructured":"Yoshihara H, Arai F, Hosokawa K, Hagiwara T, Takubo K, Nakamura Y, et al. Thrombopoietin\/MPL signaling regulates hematopoietic stem cell quiescence and interaction with the osteoblastic niche. Cell Stem Cell. 2007;1:685\u201397.","journal-title":"Cell Stem Cell"},{"key":"283_CR14","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1002\/stem.5530120606","volume":"12","author":"S Lok","year":"1994","unstructured":"Lok S, Foster DC. The structure, biology and potential therapeutic applications of recombinant thrombopoietin. STEM CELLS. 1994;12:586\u201398.","journal-title":"STEM CELLS"},{"key":"283_CR15","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0145-2126(98)00132-5","volume":"23","author":"M Albitar","year":"1999","unstructured":"Albitar M, Manshouri T, Kantarjian H, Keating M, Estrov Z, Faber J, et al. Correlation between lower c-mpl protein expression and favorable cytogenetic groups in acute myeloid leukemia. Leukemia Res. 1999;23:63\u201369.","journal-title":"Leukemia Res"},{"key":"283_CR16","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1046\/j.1365-2141.2000.02027.x","volume":"110","author":"B Lange","year":"2000","unstructured":"Lange B. The management of neoplastic disorders of haematopoiesis in children with Down\u2019s syndrome. Br J Haematol. 2000;110:512\u201324.","journal-title":"Br J Haematol"},{"key":"283_CR17","doi-asserted-by":"crossref","unstructured":"Li H, Rao Q, Yu P, Chen SY, Li Z, Xing HY, et al. Expression of MPL in leukemia stem cells and its role in stemness maintainance. Blood. 2016;128:1723.","DOI":"10.1182\/blood.V128.22.1723.1723"},{"key":"283_CR18","first-page":"297","volume":"10","author":"H Quentmeier","year":"1996","unstructured":"Quentmeier H, Zaborski M, Graf G, Ludwig WD, Drexler HG. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells. Leukemia. 1996;10:297\u2013310.","journal-title":"Leukemia"},{"key":"283_CR19","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1182\/blood-2016-04-711986","volume":"128","author":"PJ Rauch","year":"2016","unstructured":"Rauch PJ, Ellegast JM, Widmer CC, Fritsch K, Goede JS, Valk PJ, et al. MPL expression on AML blasts predicts peripheral blood neutropenia and thrombocytopenia. Blood. 2016;128:2253\u20137.","journal-title":"Blood"},{"key":"283_CR20","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1182\/blood.V82.3.877.877","volume":"82","author":"I Vigon","year":"1993","unstructured":"Vigon I, Dreyfus F, Melle J, Viguie F, Ribrag V, Cocault L, et al. Expression of the c-mpl proto-oncogene in human hematologic malignancies. Blood. 1993;82:877\u201383.","journal-title":"Blood"},{"key":"283_CR21","first-page":"1052","volume":"20","author":"P Yu","year":"2012","unstructured":"Yu P, Qiu SW, Rao Q, Lin D, Xing HY, Tang KJ. et al. Expression of c-MPL in leukemic stem cells from acute myeloid leukemia patients. Zhongguo Shi Yan Xue Ye Xue Za Zhi.2012;20:1052\u20135.","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi."},{"key":"283_CR22","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1200\/JCO.1997.15.6.2262","volume":"15","author":"M Wetzler","year":"1997","unstructured":"Wetzler M, Baer MR, Bernstein SH, Blumenson L, Stewart C, Barcos M, et al. Expression of c-mpl mRNA, the receptor for thrombopoietin, in acute myeloid leukemia blasts identifies a group of patients with poor response to intensive chemotherapy. J Clin Oncol. 1997;15:2262\u20138.","journal-title":"J Clin Oncol"},{"key":"283_CR23","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.1182\/blood-2002-10-3062","volume":"101","author":"Y Guan","year":"2003","unstructured":"Guan Y, Gerhard B, Hogge DE. Detection, isolation, and stimulation of quiescent primitive leukemic progenitor cells from patients with acute myeloid leukemia (AML). Blood. 2003;101:3142\u20139.","journal-title":"Blood"},{"key":"283_CR24","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.ccell.2018.08.007","volume":"34","author":"AL Boyd","year":"2018","unstructured":"Boyd AL, Aslostovar L, Reid J, Ye W, Tanasijevic B, Porras DP, et al. Identification of chemotherapy-induced leukemic-regenerating cells reveals a transient vulnerability of human AML recurrence. Cancer Cell. 2018;34:483\u2013498 e5.","journal-title":"Cancer Cell"},{"key":"283_CR25","first-page":"4403","volume":"60","author":"RT Costello","year":"2000","unstructured":"Costello RT, Mallet F, Gaugler B, Sainty D, Arnoulet C, Gastaut JA, et al. Human acute myeloid leukemia CD34+\/CD38- progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacities. Cancer Res. 2000;60:4403\u201311.","journal-title":"Cancer Res"},{"key":"283_CR26","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s12253-013-9696-z","volume":"20","author":"Z Dong-Feng","year":"2014","unstructured":"Dong-Feng Z, Ting L, Yong Z, Cheng C, Xi Z, Pei-Yan K. The TPO\/c-MPL pathway in the bone marrow may protect leukemia cells from chemotherapy in AML patients. Pathol Oncol Res. 2014;20:309\u201317.","journal-title":"Pathol Oncol Res"},{"key":"283_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-4-9","volume":"4","author":"JM Ninos","year":"2006","unstructured":"Ninos JM, Jefferies LC, Cogle CR, Kerr WG. The thrombopoietin receptor, c-Mpl, is a selective surface marker for human hematopoietic stem cells. J Transl Med. 2006;4:9.","journal-title":"J Transl Med"},{"key":"283_CR28","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1002\/stem.2897","volume":"36","author":"H Li","year":"2018","unstructured":"Li H, Zhao N, Li Y, Xing H, Chen S, Xu Y, et al. c-MPL is a candidate surface marker and confers self-renewal, quiescence, chemotherapy resistance, and leukemia initiation potential in leukemia. Stem Cells. Stem Cells. 2018;36:1685\u201396.","journal-title":"Stem Cells. Stem Cells"},{"key":"283_CR29","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/leu.2014.239","volume":"29","author":"K Sakashita","year":"2015","unstructured":"Sakashita K, Kato I, Daifu T, Saida S, Hiramatsu H, Nishinaka Y, et al. In vitro expansion of CD34(+)CD38(-) cells under stimulation with hematopoietic growth factors on AGM-S3 cells in juvenile myelomonocytic leukemia. Leukemia. 2015;29:606\u201314.","journal-title":"Leukemia"},{"key":"283_CR30","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3109\/10428199509051699","volume":"17","author":"D Bouscary","year":"1995","unstructured":"Bouscary D, Prudhomme C, Quesnel B, Melle J, Picard F, Dreyfus F. c-mpl expression in hematologic disorders. Leuk Lymphoma. 1995;17:19\u201326.","journal-title":"Leuk Lymphoma"},{"key":"283_CR31","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.biologicals.2017.07.006","volume":"49","author":"AK Wegehaupt","year":"2017","unstructured":"Wegehaupt AK, Roufs EK, Hewitt CR, Killian ML, Gorbatenko O, Anderson CM, et al. Recovery and assessment of leukocytes from LR Express filters. Biologicals. 2017;49:15\u201322.","journal-title":"Biologicals"},{"key":"283_CR32","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1111\/j.1537-2995.2006.00772.x","volume":"46","author":"S Neron","year":"2006","unstructured":"Neron S, Dussault N, Racine C. Whole-blood leukoreduction filters are a source for cryopreserved cells for phenotypic and functional investigations on peripheral blood lymphocytes. Transfusion. 2006;46:537\u201344.","journal-title":"Transfusion"},{"key":"283_CR33","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1073\/pnas.0308530100","volume":"101","author":"MD Feese","year":"2004","unstructured":"Feese MD, Tamada T, Kato Y, Maeda Y, Hirose M, Matsukura Y, et al. Structure of the receptor-binding domain of human thrombopoietin determined by complexation with a neutralizing antibody fragment. Proc Natl Acad Sci USA. 2004;101:1816\u201321.","journal-title":"Proc Natl Acad Sci USA"},{"key":"283_CR34","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/ng.2287","volume":"44","author":"JR Downing","year":"2012","unstructured":"Downing JR, Wilson RK, Zhang J, Mardis ER, Pui CH, Ding L, et al. The pediatric cancer genome project. Nat Genet. 2012;44:619\u201322.","journal-title":"Nat Genet"},{"key":"283_CR35","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/nature10725","volume":"481","author":"J Zhang","year":"2012","unstructured":"Zhang J, Ding L, Holmfeldt L, Wu G, Heatley SL, Payne-Turner D, et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature. 2012;481:157\u201363.","journal-title":"Nature"},{"key":"283_CR36","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/ng.2735","volume":"45","author":"J Zhang","year":"2013","unstructured":"Zhang J, Wu G, Miller CP, Tatevossian RG, Dalton JD, Tang B, et al. Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas. Nat Genet. 2013;45:602\u201312.","journal-title":"Nat Genet"},{"key":"283_CR37","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nature10733","volume":"481","author":"J Zhang","year":"2012","unstructured":"Zhang J, Benavente CA, McEvoy J, Flores-Otero J, Ding L, Chen X, et al. A novel retinoblastoma therapy from genomic and epigenetic analyses. Nature. 2012;481:329\u201334.","journal-title":"Nature"},{"key":"283_CR38","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/nature11213","volume":"488","author":"G Robinson","year":"2012","unstructured":"Robinson G, Parker M, Kranenburg TA, Lu C, Chen X, Ding L, et al. Novel mutations target distinct subgroups of medulloblastoma. Nature. 2012;488:43\u20138.","journal-title":"Nature"},{"key":"283_CR39","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.ccr.2013.11.002","volume":"24","author":"X Chen","year":"2013","unstructured":"Chen X, Stewart E, Shelat AA, Qu C, Bahrami A, Hatley M, et al. Targeting oxidative stress in embryonal rhabdomyosarcoma. Cancer Cell. 2013;24:710\u201324.","journal-title":"Cancer Cell"},{"key":"283_CR40","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/ng.2532","volume":"45","author":"L Holmfeldt","year":"2013","unstructured":"Holmfeldt L, Wei L, Diaz-Flores E, Walsh M, Zhang J, Ding L, et al. The genomic landscape of hypodiploid acute lymphoblastic leukemia. Nat Genet. 2013;45:242\u201352.","journal-title":"Nat Genet"},{"key":"283_CR41","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.ymthe.2018.03.003","volume":"26","author":"Y Arai","year":"2018","unstructured":"Arai Y, Choi U, Corsino CI, Koontz SM, Tajima M, Sweeney CL, et al. Myeloid conditioning with c-kit-Targeted CAR-T cells enables donor stem cell engraftment. Mol Ther. 2018;26:1181\u201397.","journal-title":"Mol Ther"},{"key":"283_CR42","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s12185-013-1382-0","volume":"98","author":"DJ Kuter","year":"2013","unstructured":"Kuter DJ. The biology of thrombopoietin and thrombopoietin receptor agonists. Int J Hematol. 2013;98:10\u201323.","journal-title":"Int J Hematol"},{"key":"283_CR43","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.omtm.2018.01.004","volume":"9","author":"HC Brown","year":"2018","unstructured":"Brown HC, Zakas PM, George SN, Parker ET, Spencer HT, Doering CB. Target-cell-directed bioengineering approaches for gene therapy of hemophilia A. Mol Ther Methods Clin Dev. 2018;9:57\u201369.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"283_CR44","doi-asserted-by":"crossref","first-page":"878","DOI":"10.4049\/jimmunol.145.3.878","volume":"145","author":"M Alessio","year":"1990","unstructured":"Alessio M, Roggero S, Funaro A, De Monte LB, Peruzzi L, Geuna M, et al. CD38 molecule: structural and biochemical analysis on human T lymphocytes, thymocytes, and plasma cells. J Immunol. 1990;145:878\u201384.","journal-title":"J Immunol"},{"key":"283_CR45","doi-asserted-by":"crossref","unstructured":"Chaturvedi V, Marsh RA, Lorenz AZ, Owsley E, Chaturvedi V, Nguyen T, et al. T cell activation profiles distinguish hemophagocytic lymphohistiocytosis and early sepsis. Blood 2021;137:2337\u201346.","DOI":"10.1182\/blood.2020009499"},{"key":"283_CR46","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S1074-7613(00)80353-2","volume":"7","author":"G Shubinsky","year":"1997","unstructured":"Shubinsky G, Schlesinger M. The CD38 lymphocyte differentiation marker: new insight into its ectoenzymatic activity and its role as a signal transducer. Immunity. 1997;7:315\u201324.","journal-title":"Immunity"},{"key":"283_CR47","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1158\/0008-5472.CAN-11-2778","volume":"72","author":"G Huang","year":"2012","unstructured":"Huang G, Yu L, Cooper LJ, Hollomon M, Huls H, Kleinerman ES. Genetically modified T cells targeting interleukin-11 receptor alpha-chain kill human osteosarcoma cells and induce the regression of established osteosarcoma lung metastases. Cancer Res. 2012;72:271\u201381.","journal-title":"Cancer Res"},{"key":"283_CR48","doi-asserted-by":"publisher","first-page":"9160","DOI":"10.1158\/0008-5472.CAN-04-0454","volume":"64","author":"KS Kahlon","year":"2004","unstructured":"Kahlon KS, Brown C, Cooper LJ, Raubitschek A, Forman SJ, Jensen MC. Specific recognition and killing of glioblastoma multiforme by interleukin 13-zetakine redirected cytolytic T cells. Cancer Res. 2004;64:9160\u20136.","journal-title":"Cancer Res"},{"key":"283_CR49","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1016\/j.ymthe.2017.07.009","volume":"25","author":"X Han","year":"2017","unstructured":"Han X, Cinay GE, Zhao Y, Guo Y, Zhang X, Wang P. Adnectin-based design of chimeric antigen receptor for T cell engineering. Mol Ther. 2017;25:2466\u201376.","journal-title":"Mol Ther"},{"key":"283_CR50","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1158\/1078-0432.CCR-16-0492","volume":"23","author":"A Perales-Puchalt","year":"2017","unstructured":"Perales-Puchalt A, Svoronos N, Rutkowski MR, Allegrezza MJ, Tesone AJ, Payne KK, et al. Follicle-stimulating hormone receptor is expressed by most ovarian cancer subtypes and is a safe and effective immunotherapeutic target. Clin Cancer Res. 2017;23:441\u201353.","journal-title":"Clin Cancer Res"},{"key":"283_CR51","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13045-016-0256-3","volume":"9","author":"Y Nakazawa","year":"2016","unstructured":"Nakazawa Y, Matsuda K, Kurata T, Sueki A, Tanaka M, Sakashita K, et al. Anti-proliferative effects of T cells expressing a ligand-based chimeric antigen receptor against CD116 on CD34(+) cells of juvenile myelomonocytic leukemia. J Hematol Oncol. 2016;9:27.","journal-title":"J Hematol Oncol"},{"key":"283_CR52","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.stem.2007.10.008","volume":"1","author":"H Qian","year":"2007","unstructured":"Qian H, Buza-Vidas N, Hyland CD, Jensen CT, Antonchuk J, Mansson R, et al. Critical role of thrombopoietin in maintaining adult quiescent hematopoietic stem cells. Cell Stem Cell. 2007;1:671\u201384.","journal-title":"Cell Stem Cell"},{"key":"283_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/2001-1326-2-3","volume":"2","author":"LN Abdullah","year":"2013","unstructured":"Abdullah LN, Chow EK. Mechanisms of chemoresistance in cancer stem cells. Clin Transl Med. 2013;2:3.","journal-title":"Clin Transl Med"},{"key":"283_CR54","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.mayocp.2017.05.010","volume":"92","author":"M Yogarajah","year":"2017","unstructured":"Yogarajah M, Tefferi A. Leukemic transformation in myeloproliferative neoplasms: a literature review on risk, characteristics, and outcome. Mayo Clin Proc. 2017;92:1118\u201328.","journal-title":"Mayo Clin Proc"},{"key":"283_CR55","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1200\/JCO.2005.06.027","volume":"23","author":"DA Breems","year":"2005","unstructured":"Breems DA, Van Putten WL, Huijgens PC, Ossenkoppele GJ, Verhoef GE, Verdonck LF, et al. Prognostic index for adult patients with acute myeloid leukemia in first relapse. J Clin Oncol. 2005;23:1969\u201378.","journal-title":"J Clin Oncol"},{"key":"283_CR56","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1200\/JCO.2011.40.5977","volume":"31","author":"AK Burnett","year":"2013","unstructured":"Burnett AK, Goldstone A, Hills RK, Milligan D, Prentice A, Yin J, et al. Curability of patients with acute myeloid leukemia who did not undergo transplantation in first remission. J Clin Oncol. 2013;31:1293\u2013301.","journal-title":"J Clin Oncol"},{"key":"283_CR57","doi-asserted-by":"publisher","unstructured":"Ganzel C, Sun Z, Cripe LD, Fernandez HF, Douer D, Rowe JM, et al. Very poor long-term survival in past and more recent studies for relapsed AML patients: the ECOG-ACRIN experience. Am J Hematol. 2018. https:\/\/doi.org\/10.1002\/ajh.25162.","DOI":"10.1002\/ajh.25162"},{"key":"283_CR58","doi-asserted-by":"publisher","first-page":"1593804","DOI":"10.1080\/2162402X.2019.1593804","volume":"8","author":"JT Zoine","year":"2019","unstructured":"Zoine JT, Knight KA, Fleischer LC, Sutton KS, Goldsmith KC, Doering CB, et al. Ex vivo expanded patient-derived gammadelta T-cell immunotherapy enhances neuroblastoma tumor regression in a murine model. Oncoimmunology. 2019;8:1593804.","journal-title":"Oncoimmunology"},{"key":"283_CR59","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/nrc2355","volume":"8","author":"SA Rosenberg","year":"2008","unstructured":"Rosenberg SA, Restifo NP, Yang JC, Morgan RA, Dudley ME. Adoptive cell transfer: a clinical path to effective cancer immunotherapy. Nat Rev Cancer. 2008;8:299\u2013308.","journal-title":"Nat Rev Cancer"},{"key":"283_CR60","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3389\/fonc.2019.00196","volume":"9","author":"S Patel","year":"2019","unstructured":"Patel S, Burga RA, Powell AB, Chorvinsky EA, Hoq N, McCormack SE, et al. Beyond CAR T cells: other cell-based immunotherapeutic strategies against cancer. Front Oncol. 2019;9:196.","journal-title":"Front Oncol"},{"key":"283_CR61","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3389\/fimmu.2019.00128","volume":"10","author":"M Martinez","year":"2019","unstructured":"Martinez M, Moon EK. CAR T cells for solid tumors: new strategies for finding, infiltrating, and surviving in the tumor microenvironment. Front Immunol. 2019;10:128.","journal-title":"Front Immunol"},{"key":"283_CR62","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.cell.2016.01.012","volume":"164","author":"L Morsut","year":"2016","unstructured":"Morsut L, Roybal Kole T, Xiong X, Gordley Russell M, Coyle Scott M, Thomson M, et al. Engineering customized cell sensing and response behaviors using synthetic notch receptors. Cell. 2016;164:780\u201391.","journal-title":"Cell"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41434-021-00283-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-021-00283-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-021-00283-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T08:30:07Z","timestamp":1673080207000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41434-021-00283-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,13]]},"references-count":62,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["283"],"URL":"https:\/\/doi.org\/10.1038\/s41434-021-00283-5","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,13]]},"assertion":[{"value":"27 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}